---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-203894"
form_type: "8-K"
ticker: null
cik: "0001501756"
company_name: "Adverum Biotechnologies, Inc."
filed_at: "2023-08-04T23:59:59+00:00"
generated_at: "2026-06-12T05:54:48.598672+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Adverum appoints Linda Rubinstein as full-time CFO; $485K salary, 850K share option

## Summary
- Linda Rubinstein transitions from consulting CFO (via FLG Partners) to full-time CFO effective Aug 3, 2023.
- Base salary $485,000; target bonus 40%; option for 850,000 shares vesting over 36 months with 25% cliff at 6 months.
- Severance: 12 months salary plus equity vesting if termination near change in control; 9 months otherwise; reduced to 3 months in first year.
- Consulting agreement with FLG Partners terminated as of start date.

## SEC filing metadata
- accession: 0001193125-23-203894
- form_type: 8-K
- cik: 0001501756
- company_name: Adverum Biotechnologies, Inc.
- filed_at: 2023-08-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501756/000119312523203894/0001193125-23-203894-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501756/000119312523203894/d466076d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-203894
- JSON: https://secwatch.observer/filing/0001193125-23-203894.json
- Plain text: https://secwatch.observer/filing/0001193125-23-203894.txt

## Key facts
- Executive change
  Linda Rubinstein was appointed as Chief Financial Officer at Adverum Biotechnologies, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On August 3, 2023, Ms. Rubinstein and Adverum entered into an employment offer letter (the “Offer Letter”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501756/000119312523203894/0001193125-23-203894-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.